France’s Ipsen clears FDA hurdle for bone disorder drug Sohonos
HQ Team August 17, 2023: Ipsen, a French drugmaker, has received FDA approval for its Sohonos capsules to treat a rare bone disorder.
Drugs
Health
Pharma